Literature DB >> 826237

Fat overload with a 10% soybean oil emulsion.

R P Belin, B A Bivins, J Z Jona, V L Young.   

Abstract

A 10% soybean oil emulsion (Intralipid) has been demonstrated to be an effective means of delivering an adequate caloric intake via a peripheral vein. This emulsion has generally been considered safe and free of significant complications. This is a report of a child who initially thrived on this intravenously administered fat emulsion, then suddenly developed a lifethreatening intolerance to the infusion, which appeared to be the "fat overload syndrome." This syndrome, seen frequently with earlier fat emulsions, has not been reported previously as a complication of the 10% soybean oil emulsion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826237     DOI: 10.1001/archsurg.1976.01360300081013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

1.  Splenic macrophages in preterm infants: a necropsy study.

Authors:  S Variend; A Drummond; R Coombs
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 2.  Parenteral nutrition: current status and concepts.

Authors:  G D Phillips; C L Odgers
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

3.  Fat overload from 10 percent soybean oil emulsion in a marrow transplant recipient.

Authors:  R F Taylor; C D Buckner
Journal:  West J Med       Date:  1982-04

4.  Intralipid causing adult respiratory distress syndrome.

Authors:  J Bass; W Friedl; W Jeranek
Journal:  J Natl Med Assoc       Date:  1984-04       Impact factor: 1.798

5.  Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.

Authors:  P Schöffski; M Freund; R Wunder; D Petersen; C H Köhne; H Hecker; U Schubert; A Ganser
Journal:  BMJ       Date:  1998-08-08

6.  Parenteral safflower oil emulsion (Liposyn 10%): safety and effectiveness in treating or preventing essential fatty acid deficiency in surgical patients.

Authors:  B A Bivins; R P Rapp; K Record; H C Meng; W O Griffen
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.